CEP HOOF RX Trademark

Trademark Overview


On Tuesday, October 8, 2024, a trademark application was filed for CEP HOOF RX with the United States Patent and Trademark Office. The USPTO has given the CEP HOOF RX trademark a serial number of 98789972. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, March 26, 2025. The CEP HOOF RX trademark is filed in the Pharmaceutical Products category with the following description:

Dietary and nutritional supplements for horses
cep hoof rx

General Information


Serial Number98789972
Word MarkCEP HOOF RX
Filing DateTuesday, October 8, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, March 26, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDietary and nutritional supplements for horses
NOT AVAILABLE"HOOF RX"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 8, 2024
Primary Code005
First Use Anywhere DateMonday, April 19, 2021
First Use In Commerce DateMonday, April 19, 2021

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressMuldrow, OK 74948

Trademark Events


Event DateEvent Description
Tuesday, October 8, 2024NEW APPLICATION ENTERED
Tuesday, October 8, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 20, 2025ASSIGNED TO EXAMINER
Wednesday, March 26, 2025NON-FINAL ACTION E-MAILED
Wednesday, March 26, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 26, 2025NON-FINAL ACTION WRITTEN